GLP-1 drugs are reportedly influencing eating habits, with a trend towards high protein intake emerging. This shift is affecting the food industry, with companies adapting to increased demand for protein-rich products and restaurants modifying their menus to offer smaller portions with more protein. The impact of GLP-1s on protein demand is also being felt in the supply chain, with some outlets noting a shortage of certain protein sources.